Sponsors of the 2018 Swiss-Chinese Life Sciences Forum







Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.






As economic powerhouses in their respective regions and globally renowned hubs for life sciences, Basel and Shanghai joined forces by entering a sister city partnership in 2007. The partnership focuses on collaboration in business, research and education while also extending to areas like culture and tourism. The goal of the partnership is to create substantial benefits for all parties involved, and the various projects implemented over the past years are proof of its success. The sister city partnership is managed by External Relations & Marketing of the Presidential Department of the Canton of Basel-Stadt.











Asymchem is an innovative solution provider in the life science industry, committed to supporting pharmaceutical development with its cutting-edge technologies and manufacturing platform. The company was established in 1998, and has become a USFDA-inspected CDMO with extensive R&D technologies and scale-up experiences, and state-of-the-art facilities across China. With strong expertise in a range of niche technologies such as continuous flow, biotransformation, peptides, ADCs and the development and manufacture of highly-potent compounds, we are well placed to act as a reliable, long-term partner for clients looking to develop new biopharmaceutical drugs with our unique one-stop service.

Asymchem have a perfect track-record of inspection with key regulatory authorities such as the USFDA and Australian TGA and a long history of working with valuable clients to provide the necessary support for a successful filing (NDA/DMF) and our comprehensive drug product and clinical CRO services can provide even greater support for those clients looking to launch their compound in China.













With 2,150 employees at 10 locations in Switzerland and one location in Liechtenstein, KPMG Switzerland is a leading service provider in the areas of Audit, Tax and Advisory: audits for creating the transparency and trust integral to good corporate governance, and tax and advisory services for successful, comprehensive company management. Through its strong regional presence KPMG is close to you, helping you navigate today's turbulences to find tomorrow's answers.

KPMGs life sciences experts located throughout Switzerland have abundant experience and a deep understanding of the industry. KPMG supports life sciences companies in challenges around strategy, transactions, sales & operations, compliance & regulations, digitalization, innovation, finance, tax management and assurance. To cover your needs anywhere in the world, the Swiss team works closely with experts in the KPMG global network.

Responding to the increasingly active investments between China and Europe, KPMG China Desk Switzerland provides a one-stop-shop solution for China-related business requests. Its unique and complete expertise network has cross-cultural background, in-depth insights of Chinese and European markets, as well as profound experiences in various industries. KPMG China Desk closely works with all KPMG service lines and global partners, and aims to establish a business hub bridging Chinese and European markets.